Skip to main content

PX19 Antibody [Biotin]

Novus Biologicals, part of Bio-Techne | Catalog # NBP3-46900B

Catalog #
Availability
Size / Price
Qty
Loading...
NBP3-46900B

Key Product Details

Species Reactivity

Human, Mouse, Rat

Applications

ELISA, Immunohistochemistry

Label

Biotin

Antibody Source

Polyclonal Rabbit IgG

Concentration

Please see the vial label for concentration. If unlisted please contact technical services.

Product Specifications

Immunogen

PRELI domain containing 1. (Uniprot# Q9Y255)

Clonality

Polyclonal

Host

Rabbit

Isotype

IgG

Applications for PX19 Antibody [Biotin]

Application
Recommended Usage

ELISA

Optimal dilutions of this antibody should be experimentally determined.

Immunohistochemistry

Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.

Formulation, Preparation, and Storage

Purification

Immunogen affinity purified

Formulation

PBS

Preservative

0.05% Sodium Azide

Concentration

Please see the vial label for concentration. If unlisted please contact technical services.

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Store at 4C in the dark.

Background: PX19

PX19 may be important for the development of vital and immunocompetent organs

Alternate Names

25 kDa protein of relevant evolutionary and lymphoid interest, CGI-106, MGC87972, PRELI domain containing 1, PRELImitochondrial, protein of relevant evolutionary and lymphoid interest

Gene Symbol

PRELID1

Additional PX19 Products

Product Documents for PX19 Antibody [Biotin]

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for PX19 Antibody [Biotin]

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Loading...
Loading...
Loading...
Loading...